KromaTiD provides innovative solutions for the discovery, detection and quantification of genomic structural variations. With our dGH™ platform, we are able to observe gene editing-associated rearrangements in their chromosomal structural context. The data is complementary to sequencing and our assays provide researchers and innovators in gene editing with an additional dimension of data to support optimization of process variables, quantitation of structural off-target effects, and tracking of durable genomic changes over time.
Location: United States, Colorado, Longmont
Member count: 11-50
Total raised: $2M
Founded date: 2007
Investors 2
| Date | Name | Website |
| - | First Capi... | firstcapit... |
| - | BroadOak C... | broadoak.c... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 28.04.2021 | - | $2M | - | prnewswire... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 28.04.2021 | KromaTiD R... | LONGMONT, Colo., April 28, 2... | - | - | prnewswire... |
| 11.02.2021 | KromaTiD A... | LONGMONT, Colo., Feb. 11, 20... | - | - | prnewswire... |
| 13.08.2019 | KromaTiD C... | KromaTiD, Inc., a Longmont, Co... | USA | - | finsmes.co... |
| 19.07.2011 | Variation ... | Vaccine developer Variation ... | - | - | vcnewsdail... |